Sino Medical Sciences Technology (SHA:688108) received regulatory approvals from Argentina and Ecuador for its HT Supreme drug-eluting stent system and related coronary devices.
The devices are designed for coronary artery treatment and feature advanced biodegradable coatings, according to a Friday filing with the Shanghai bourse.
Shares of the medical device manufacturer closed 7% higher Friday.